<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Owens Byrne | Activity</title>
	<link>https://www.catswannabecats.com/members/swingpan06/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/swingpan06/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Owens Byrne.</description>
	<lastBuildDate>Mon, 06 Jul 2026 08:03:58 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">159960246190e4c5573d6f3f9d05540f</guid>
				<title>Owens Byrne posted an update: 42-0.94, p=0.02), NANOG rs10744044 (any A allele vs G/G, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22023/</link>
				<pubDate>Sat, 07 Jun 2025 07:12:03 -0400</pubDate>

									<content:encoded><![CDATA[<p>42-0.94, p=0.02), NANOG rs10744044 (any A allele vs G/G, HR=0.59, 95% CI=0.39-0.90, p=0.01), NANOGP8 rs2168958 (any C allele vs A/A, HR=2.12, 95% CI=1.36-3.29, p&lt;0.001)and NANOGP8 rs2279066 (any C allele vs T/T, HR=1.80, 95% CI=1.06-1.68, p=0.03). Multivariate analysis confirmed the significant associations for NANOGP8 rs2168958 and NANOGP8&hellip;<span class="activity-read-more" id="activity-read-more-22023"><a href="https://www.catswannabecats.com/activity/p/22023/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">45d001a97f0230292c3966debdbc105d</guid>
				<title>Owens Byrne posted an update: 3% samples had enough tumor material for genomic genotyping, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/8950/</link>
				<pubDate>Sat, 31 May 2025 21:55:25 -0400</pubDate>

									<content:encoded><![CDATA[<p>3% samples had enough tumor material for genomic genotyping, and 96.6% for PD-L1 immunohistochemistry. A good concordance was found between both sources of material 88.9% for PD-L1, 100% for NGS and nCounter. <a href="https://www.selleckchem.com/products/BI-2536.html" rel="nofollow ugc">BI 2536 mw</a> EBUS-TBNA is a feasible alternative source of material for NSCLC genotyping and allows the identification of patient candidates&hellip;<span class="activity-read-more" id="activity-read-more-8950"><a href="https://www.catswannabecats.com/activity/p/8950/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0daed25cb3bd655ba7c6a40374b3d5f4</guid>
				<title>Owens Byrne became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8770/</link>
				<pubDate>Sat, 31 May 2025 21:39:25 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>